Pura Vida Investments’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-20,000
Closed -$2.02M 58
2023
Q3
$2.02M Buy
+20,000
New +$2.3M 0.38% 60
2023
Q1
Sell
-55,400
Closed -$4.91M 100
2022
Q4
$4.91M Buy
+55,400
New +$4.6M 0.25% 93
2022
Q2
Sell
-89,000
Closed -$13.2M 224
2022
Q1
$13.2M Sell
89,000
-19,400
-18% -$2.71M 0.43% 61
2021
Q4
$15.4M Buy
+108,400
New +$15.4M 0.56% 44

Other funds holding CNMD

Pura Vida Investments's CNMD Position: Q2 2021 in Review

Pura Vida Investments sold out of CONMED (CNMD) in Q2 2021, closing a stake of 65,000 shares — an estimated $8.49M sold.

Pura Vida Investments first reported a position in CNMD in Q1 2015 and held it in 9 quarters. The position peaked at $15.7M in Q3 2020. 252 funds tracked by Wall St. Rank hold CNMD as of Q2 2021.

  • Pura Vida Investments reported no remaining CONMED position as of Q2 2021 after selling out during the quarter.
  • Pura Vida Investments sold 65,000 CONMED shares in Q2 2021, an estimated $8.49M.
  • Pura Vida Investments first reported a position in CONMED in Q1 2015 and held it in 9 quarters.
  • Pura Vida Investments's CONMED position peaked at $15.7M in Q3 2020.
  • 252 funds tracked by Wall St. Rank held CONMED as of Q2 2021.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.